Table 2.
Predictors of response to treatment with OnabotA. Univariate and multivariate regression analysis.
| Variable | Analysis | OR | IC 95% | p-Value |
|---|---|---|---|---|
| Age at the time of the first OnabotA session | Univariate Multivariate |
−0.017 | (−0.060)–(0.026) | 0.436 |
| Age of migraine onset | Univariate Multivariate |
0.095 0.080 |
(−0.028)–(0.218) (−0.064)–(0.224) |
0.130 0.275 |
| Years with migraine before OnabotA treatment | Univariate Multivariate |
−0.025 −0.007 |
(−0.123)–(0.073) (−0.122)–(0.108) |
0.615 0.902 |
| Months with CM before OnabotA treatment. | Univariate Multivariate |
−0.013 −0.033 |
(−0.039)–(0.012) (−0.059)–(0.007) |
0.312 0.013 |
| Sex | Univariate Multivariate |
−1.040 | (−4.374)–(2.294) | 0.540 |
| Headache days per month | Univariate Multivariate |
0.474 0.540 |
0.278–0.670 0.333–0.746 |
p < 0.001 p < 0.001 |
| Medication overuse | Univariate Multivariate |
0.454 −0.509 |
(−2.302)–(3.210) (−3.225)–(2.206) |
0.746 0.712 |
| Number of previous preventive treatments | Univariate Multivariate |
−0.047 −0.012 |
(−0.766)–(0.673) (−0.703)–(0.678) |
0.898 0.972 |